About the 2023 POPIA Program
Applications will be reviewed by an independent, non-Bayer review panel composed of experienced representatives from the clinical and patient advocacy communities.
Duration of Award: 1 Year
Award Value: Two awards in the amount of $50,000 USD each.
2023 POPIA Program Timeline
| Action | Dates |
|---|---|
| Applications open | April 24, 2023 |
| Deadline for entries | June 16, 2023 |
| Applications reviewed by REVIEW PANEL | June/July 2023 |
| Applicants chosen to submit a full proposal | July 18, 2023 |
| Full Proposal submission deadline | August 1, 2023 |
| Applicants notified of decision | September 1, 2023 |
| ANNOUNCEMENT OF WINNERS ESMO 2023 | October 20-24, 2023 |
Improve access to tumor testing to inform patient diagnosis and care
Address inequalities and barriers in precision medicine that impact cancer communities
Improve community education, training, and awareness in precision medicine, including tumor tissue testing for genomic and oncogenic drivers
Applications will be accepted from NGOs that are Non-governmental patient organizations and Non-governmental healthcare institutions, unless prohibited by national law.
Applications from individuals will not be allowed.
Collaborations between institutions, including between patient groups and research facilities, are welcome.
Please designate a lead organization in the application.
You may apply to support a new initiative or to support the continued rollout/expansion of an existing program. Applying for the grant does not preclude you from seeking other sources of funding. Although the award is for 1 year, your program can continue beyond the year.
Initiatives should be focused on precision oncology and may include, but are not limited to:
- Health intervention programs such as a community testing or community training program
- Testing algorithm tool
- Survey
- Communications tool (eg, help to interpret complex information on cancer type or tests)
- Public health initiative
- Education resources for healthcare professionals or patients/care partners (eg, online tool, infographic, website, animation, events, printed materials)
- Awareness campaign
- Digital health/technology project publication
Interventional clinical trials and translational research studies are not included in the awards.
Bayer provides other forms of scientific partnership in focused areas of research, which are listed on its corporate website.
The grant amount requested in funding cannot exceed 25% of an organization’s overall funding.
Program must be nonpromotional and should not include mention of any particular medicine. Program may refer to class of treatment.
Program should be initiated within 1 year of receiving funds, and metrics should be reported by an agreed-upon date.
Applications should comply with program criteria.
Successful applicants will be announced publicly. Bayer will make every effort to help successful applicants share their programs with the wider cancer community.
